Healthcare >> CEO Interviews >> January 10, 2001
JOHN W. JACKSON has been Chairman and Chief Executive Officer of Celgene
since January 1996. Prior to joining Celgene, Mr. Jackson held senior
positions with Merck and American Cyanamid. He holds a BA from Yale
University and an MBA from INSEAD, in France. He served as a U.S. Marine
infantry officer in Vietnam. Profile
investor audience.
Mr. Jackson: Celgene was founded as a spin-off from Celanese and went
public in 1987. Our original focus
